APA (7th ed.) Citation

Boyce, C. L., Sils, T., Milne, R. S., Wallner, J. J., Hardy, S. R., Ko, D., . . . Team, P. M. a. I. S. E. S. (2024). Impact of Human Immunodeficiency Virus Drug Resistance Mutations Detected in Women Prior to Antiretroviral Therapy With Efavirenz + Tenofovir Disoproxil Fumarate + Lamivudine (or Emtricitabine). Open Forum Infectious Diseases, 11(7), 1. https://doi.org/10.1093/ofid/ofae383

Chicago Style (17th ed.) Citation

Boyce, Ceejay L., et al. "Impact of Human Immunodeficiency Virus Drug Resistance Mutations Detected in Women Prior to Antiretroviral Therapy With Efavirenz + Tenofovir Disoproxil Fumarate + Lamivudine (or Emtricitabine)." Open Forum Infectious Diseases 11, no. 7 (2024): 1. https://doi.org/10.1093/ofid/ofae383.

MLA (9th ed.) Citation

Boyce, Ceejay L., et al. "Impact of Human Immunodeficiency Virus Drug Resistance Mutations Detected in Women Prior to Antiretroviral Therapy With Efavirenz + Tenofovir Disoproxil Fumarate + Lamivudine (or Emtricitabine)." Open Forum Infectious Diseases, vol. 11, no. 7, 2024, p. 1, https://doi.org/10.1093/ofid/ofae383.